What Actually Happens in Your Second Week on Mounjaro

The real decision at week two: carry on, adjust, or flag something?

Week two tends to feel anticlimactic for a lot of people. The appetite suppression that friends or forums describe hasn't fully arrived. The scales haven't shifted dramatically. You might be wondering whether you've done something wrong, or whether this particular medicine simply isn't for you. Neither is likely true.

Mounjaro's first month exists specifically to acclimatise your digestive system, not to deliver peak effect. The starter dose keeps side effects manageable while your body learns to work with a dual GIP and GLP-1 receptor agonist, a mechanism that influences both appetite signalling and how quickly food leaves your stomach. That's a meaningful biological shift. It doesn't happen overnight.

The decision you're actually facing at week two is a simpler one: are the side effects tolerable, and is anything happening that warrants a call to your prescriber? If yes to the first and no to the second, the most evidence-based thing you can do is stay the course. If something feels wrong rather than just uncomfortable, that changes the calculus, and your prescriber should hear about it. For a broader picture of how Mounjaro progresses across the full titration schedule, the week-by-week breakdown puts week two in context.

Side effects in week two: what's typical and what isn't

Nausea is the side effect most commonly reported in the early weeks, followed by loose stools, constipation, indigestion, burping, and fatigue. These are well-documented in the clinical trial data and listed in the NHS's patient-level information on tirzepatide. For most people they peak around a dose increase and then settle, but in week two, you're still in the thick of the initial adjustment.

A few things that genuinely help: eating smaller portions and stopping before you feel full, avoiding rich or fatty meals that slow digestion further, keeping fluids up, and not lying down straight after eating. These aren't just comfort tips; nausea from slowed gastric emptying is worsened by volume and fat content.

What isn't typical: severe abdominal pain, especially pain that reaches through to your back, with or without vomiting. That's a signal to get medical help quickly, it's the pattern associated with acute pancreatitis, a known but uncommon risk flagged by the MHRA in their January 2026 Drug Safety Update for GLP-1 medicines. The same applies to signs of a serious allergic reaction or significant dehydration from persistent vomiting or diarrhoea. When in doubt, seek help rather than wait.

Appetite and weight changes, or the lack of them

Some people notice a real reduction in hunger by day three or four. Others reach the end of the Mounjaro second week and aren't sure anything has changed at all. Both experiences are well within the normal range at 2.5 mg. The appetite-suppressing effect of tirzepatide tends to become more pronounced as the dose increases, many of the clinical outcomes you may have read about were measured at higher doses over 72 weeks, as reported in the SURMOUNT-1 trial published in the New England Journal of Medicine.

That's not a reason to rush ahead. Dose escalation is a clinical decision, timed to balance effectiveness against tolerability. If you're tempted to look at what week five or six feels like for most people, the week-five overview gives a realistic picture of where appetite changes typically sit by that point, and it may reassure you that the early weeks are the slow part of the curve.

One thing worth monitoring honestly: food noise. Many people describe a quieting of constant background thoughts about food, sometimes before the scales move at all. If that's starting to happen for you, it's a sign the medicine is doing something, even if it doesn't yet look like much on the outside. You can also read more about the broader positive effects people notice on Mounjaro as treatment progresses.

Practical questions your prescriber can actually answer

It's easy to feel like week two is too early to reach out, surely you should have more to report? In practice, the questions that come up at this stage are exactly the ones a prescriber needs to hear. Whether your side effects are manageable, whether any existing medicines need reconsidering, whether your injection technique needs a check, none of that is premature to raise. If you've used Mounjaro before and are restarting, you may also find it helpful to read about whether Mounjaro works second time around, including what typically affects outcomes when returning to treatment.

Women using oral contraceptive pills should note that tirzepatide can reduce absorption during the first four weeks of treatment and for four weeks after any dose increase; adding a non-oral method during those windows is the guidance recommended by the NHS. If that's relevant to you, it's worth raising now rather than later. The NHS England resource on weight management injections covers contraception and other practical considerations in detail.

If you're wondering what to expect from the full arc of treatment, understanding how tirzepatide works as a medicine gives useful background, and for anyone restarting after a break, there is specific guidance on whether Mounjaro is as effective second time round that is worth reviewing before your next prescriber conversation. And if cost or next steps feel uncertain, our treatment overview page covers what a private prescription through a clinician-led service actually involves. Speak to our prescribers if anything about week two feels unclear, that's what they're there for, seven days a week.